Monday, January 12, 2009
"FDA Is Lax on Oversight During Trials, Inquiry Finds"
That's the title of a Gardiner Harris article in today's NY Times. The opening:
The Food and Drug Administration does almost nothing to police the financial conflicts of doctors who conduct clinical trials of drugs and medical devices in human subjects, government investigators are reporting.
Moreover, the investigators say, agency officials told them that trying to protect patients from such conflicts was not worth the effort.
(Oh, as usual: I've done some consulting work for pharma companies, though it's been quite a while now.)